Previous Article | Next Article ![]()
Infect. Immun., 11 1997, 4725-4733, Vol 65, No. 11
U Fagin, U Hahn, J Grotzinger, B Fleischer, D Gerlach, F Buck, A Wollmer, H Kirchner and L Rink
The streptococcal erythrogenic exotoxin A (SPEA) belongs to the family of
bacterial superantigens and has been implicated in the pathogenesis of a
toxic shock-like syndrome and scarlet fever. Concerning its biological
activity, mainly T-cell-stimulatory properties, conflicting data exist. In
this study, we show that most of the SPEA preparations used so far contain
biologically active contaminations. Natural SPEA from the culture
supernatant of Streptococcus pyogenes NY-5 and recombinant SPEA purified
from the culture filtrate of S. sanguis are strongly contaminated with
DNases. We show that natural SPEA induces more tumor necrosis factor alpha
(TNF-alpha) than recombinant SPEA, but we also show that DNases are able to
induce TNF-alpha. In commercial SPEA preparations, we identified a highly
active protease, which was shown not to be SPEB. To exclude these
contaminations, we overexpressed SPEA cloned in the effective high-level
expression vector pIN-III-ompA2 in Escherichia coli. The expressed SPEA
shows the same amino acid composition as natural SPEA, whereas functional
studies reported so far were carried out with toxins containing an
incorrect amino terminus. We describe the rapid purification of
lipopolysaccharide-, DNase-, and protease-free SPEA in two steps from the
host's periplasm and its structural characterization by circular dichroism.
Our results represent for the first time the production in E. coli of
recombinant SPEA with the authentic N-terminal sequence and a proven
superantigenic activity. Collectively, our results indicate that
immunological studies of superantigens require highly purified substances
free of biologically active contaminations.
Copyright © 1997, American Society for Microbiology
Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli
Institute of Immunology and Transfusion Medicine, University of Lubeck School of Medicine, Germany.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|